Denied

No. 23-267

Marilyn Williams v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.

from the United States Court of Appeals for the Eleventh Circuit

See other cases from the Eleventh Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 2/16/2024.

Reply of petitioner Marilyn Williams filed.

Brief of respondents Boehringer Ingelheim Pharmaceuticals, Inc. et al. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including December 22, 2023.

Motion to extend the time to file a response from December 6, 2023 to December 22, 2023, submitted to The Clerk.

Response Requested. (Due December 6, 2023)

DISTRIBUTED for Conference of 11/17/2023.

Waiver of right of respondents Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. to respond filed.

Petition for a writ of certiorari filed. (Response due October 20, 2023)

Application (23A79) granted by Justice Thomas extending the time to file until September 15, 2023.

Application (23A79) to extend the time to file a petition for a writ of certiorari from August 16, 2023 to October 15, 2023, submitted to Justice Thomas.

Parties

Marilyn Williams, Petitioner, represented by Jonathan F. Mitchell

Marilyn Williams, Petitioner, represented by Ashley Conrad Keller

Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp., Respondent, represented by Paul Alessio Mezzina

 
Last updated: July 24, 2024